Metraipolis › archive › dc_fe047fcaa195

Engineered probiotics platform for oral delivery of antibody as a high-compliance alternative for immune-mediated inflammatory diseases — Europe PMC PMID:41421354

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41421354
DOI: 10.1016/j.xcrm.2025.102523
License (as archived): solo-consultazione
Archived: 2026-11-07T12:52:15.031Z
SHA-256 of the archived text: 8369e71893efa5af7d300f9953964bc80ff129bd3cf624685213f3b0055675d3
Stable URL of this page: https://metraipolis.com/documento/dc_fe047fcaa195

How to cite

Engineered probiotics platform for oral delivery of antibody as a high-compliance alternative for immune-mediated inflammatory diseases — Europe PMC PMID:41421354 — Europe PMC (en), https://europepmc.org/article/MED/41421354 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fe047fcaa195 (Metraipolis archive dc_fe047fcaa195, sha256 8369e71893efa5af7d300f9953964bc80ff129bd3cf624685213f3b0055675d3)

BibTeX

@misc{dcfe047fcaa195,
  title = {Engineered probiotics platform for oral delivery of antibody as a high-compliance alternative for immune-mediated inflammatory diseases — Europe PMC PMID:41421354},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41421354},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fe047fcaa195; sha256 8369e71893efa5af7d300f9953964bc80ff129bd3cf624685213f3b0055675d3},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41421354. Agents can read the archived copy with the MCP tool read_document.